Runben Biotechnology Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	305.33	300.16	226.03	160.04	120.65	94.71
Depreciation & Amortization	20.91	20.91	21.87	19.77	10.53	8.01
Other Amortization	0.37	0.37	0.11	-	-	-
Loss (Gain) From Sale of Assets	0.51	0.51	-0.07	-0.05	-0	-
Asset Writedown & Restructuring Costs	-3.5	-3.5	-	0	0.02	0
Loss (Gain) From Sale of Investments	-3.86	-3.86	-0.84	-2.05	-1.96	-1.11
Provision & Write-off of Bad Debts	0.47	0.47	0.2	-0.02	-0	0.02
Other Operating Activities	9.27	-26.05	-11.5	1.62	2.71	0.79
Change in Accounts Receivable	-23.06	-23.06	10.38	-2.43	-6.44	-1.98
Change in Inventory	-27.48	-27.48	7.39	-46.95	-14.09	-16.43
Change in Accounts Payable	41.72	41.72	3.71	43.2	27.73	3.32
Change in Other Net Operating Assets	0.64	0.64	1.42	0.9	2.68	0.07
Operating Cash Flow	297.73	257.24	252.52	165.32	138.65	87.14
Operating Cash Flow Growth	23.01%	1.87%	52.74%	19.24%	59.12%	40.74%
Capital Expenditures	-103.05	-74.22	-13.65	-40.65	-152.03	-58.2
Sale of Property, Plant & Equipment	0.55	0.1	0	0.14	0	-
Investment in Securities	-13.94	-263.83	-1,301	48	-14.43	-17.52
Other Investing Activities	36.52	41.03	4.73	2.05	2.32	0.75
Investing Cash Flow	-79.91	-296.92	-1,310	9.53	-164.14	-74.98
Long-Term Debt Repaid	-	-1.52	-2.34	-2.92	-	-
Net Debt Issued (Repaid)	-1.52	-1.52	-2.34	-2.92	-	-
Issuance of Common Stock	-	-	995.48	-	225.66	17.99
Common Dividends Paid	-241.24	-136.04	-	-3.44	-30.95	-
Other Financing Activities	4.95	-	-20.3	-3.03	-6.32	-1.74
Financing Cash Flow	-237.81	-137.56	972.84	-9.39	188.39	16.25
Foreign Exchange Rate Adjustments	-0.02	0	-	-	0.24	-
Net Cash Flow	-20.01	-177.24	-84.32	165.47	163.15	28.41
Free Cash Flow	194.68	183.02	238.87	124.67	-13.38	28.93
Free Cash Flow Growth	0.23%	-23.38%	91.60%	-	-	-33.37%
Free Cash Flow Margin	12.82%	13.88%	23.13%	14.56%	-2.30%	6.53%
Free Cash Flow Per Share	0.48	0.45	0.68	0.37	-0.04	0.10
Cash Income Tax Paid	176.15	162.07	127.8	77.47	58.49	49.7
Levered Free Cash Flow	1,053	134.87	180.69	59.89	-30.47	-6.14
Unlevered Free Cash Flow	1,053	134.96	180.85	60.16	-30.13	-6.14
Change in Working Capital	-31.76	-31.76	16.73	-13.99	6.71	-15.29

Source: S&P Global Market Intelligence. Standard template. Financial Sources.